Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
7.78
-0.13 (-1.58%)
Apr 28, 2025, 1:11 PM EDT - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $1.16 billion as of April 28, 2025. Its market cap has increased by 198.20% in one year.
Market Cap
1.16B
Enterprise Value
1.12B
1-Year Change
198.20%
Ranking
Category
Stock Price
$7.78
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.16B, a decrease of -75.80%. That is a compound annual growth rate of -21.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |